Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial

Background. An exploratory subanalysis of the ODIN trial was performed to evaluate the efficacy of darunavir/ritonavir (DRV/r) 800/100 mg OD versus 600/100 mg BID in patients who were NNRTI-experienced but PI-naïve. Methods. ODIN was a phase III, 48-week study comparing DRV/r OD versus BID in 590 tr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:AIDS Res Treat
Päätekijät: Geretti, Anna Maria, Moeketsi, Mathe, Demasi, Ralph, van Delft, Yvon, Mohammed, Perry
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4555450/
https://ncbi.nlm.nih.gov/pubmed/26357568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/962574
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia